Connecticut SB 545: AN ACT CONCERNING A STUDY OF REQUESTS BY HEALTH CARE PROVIDERS TO OVERRIDE STEP THERAPY DRUG REGIMENS FOR CERTAIN CANCER PATIENTS.

Status: Reserved for Subject Matter Public Hearing (as of 2017-01-26)

State: Connecticut · Session: 2017 · Bill: SB 545

Subjects: Cancer, Drugs, Insurance Department, Reports, Studies

Sponsors: b'Kennedy, Ted'

View Connecticut SB 545 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.